About this trial
This cross-sectional study aims to ascertain the mechanical properties of human carotid/femoral atherosclerotic plaque and abdominal aortic aneurysm tissue and correlate tissue mechanics with novel blood-based biomarkers of cardiovascular calcification.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with arterial plaque undergoing treatment where the plaque tissue will be surgically removed as per the usual peripheral endarterectomy procedure.
Able to provide informed consent.
Disqualifiers
Patients that are unable to give informed consent.
Seriously ill/unconscious patients.
Trial population
Patients eligible for peripheral endarterectomy of the carotid/femoral artery or abdominal aortic aneurysm surgery to remove artery blockage will be invited to take part in this study with no restrictions on patient type.
Trial design
Cohort
Prospective
Treatments tested in this trial
No intervention.
Other interventionNo intervention.
Treatment groups
Trial outcomes
Primary outcomes
Calcification feature classification
Identification of particular calcification features of plaque tissue and their influence on mechanical properties which may help clarify the success of stenting in certain patient cohorts compared to others and elucidate the procedural risk of endovascular treatments in plaque with certain calcification types.
Biomarker Analysis
Identification of novel biomarkers of vascular calcification could potentially be used as a predictive tool to highlight those at greatest risk of adverse peri-operative events, to allow for tailored medical treatment approaches and to stream-line patient care and improve patient outcomes.
Secondary outcomes
Cardiovascular Health Critical Mass
To build a critical mass in cardiovascular health, an area of strategic importance for healthcare in Ireland.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.